This site uses cookies to store information on your computer. Learn more x

Consensus Figures

A number of international financial analysts cover DSM. The most recent consensus figures – provided by Vara Research – are detailed below. The figures are based on the estimates given by the banks that were approached by Vara Research.

Analysts' consensus Q3 2017 and FY 2017 published 15 September 2017

  Q3 2016 FY 2016 Q3 2017 E FY 2017 E
Sales (continuing)        
  Number of Estimates     16 20
  Highest     2,156 8,606
  Consensus 1,998 7,920 2,077 8,438
  Median     2,076 8,442
  Lowest     2,011 8,277
EBITDA (continuing)        
  Number of Estimates     16 20
  Highest     370 1,430
  Consensus 323 1,262 351 1,402
  Median     351 1,402
  Lowest     339 1,345
EBIT (continuing)        
  Number of Estimates     15 20
  Highest     250 951
  Consensus 205 791 231 913
  Median     229 916
  Lowest     220 833
Nutrition, Sales        
  Number of Estimates     16 18
  Highest     1,376 5,538
  Consensus 1,303 5,169 1,332 5,433
  Median     1,336 5,449
  Lowest     1,290 5,249
Nutrition, EBITDA        
  Number of Estimates     16 18
  Highest     268 1,063
  Consensus 231 931 254 1,030
  Median     253 1,030
  Lowest     244 1,002
Nutrition, EBIT        
  Number of Estimates     15 16
  Highest     195 772
  Consensus 159 645 181 740
  Median     181 739
  Lowest     171 714
Materials, Sales        
  Number of Estimates     15 18
  Highest     716 2,827
  Consensus 634 2,513 682 2,768
  Median     683 2,779
  Lowest     637 2,678
Materials, EBITDA        
  Number of Estimates     16 18
  Highest     129 487
  Consensus 118 435 122 472
  Median     123 471
  Lowest     110 455
Materials, EBIT        
  Number of Estimates     15 16
  Highest     98 362
  Consensus 86 311 90 345
  Median     91 344
  Lowest     78 328
Innovation Center, Sales        
  Number of Estimates     15 17
  Highest     48 184
  Consensus 43 167 44 173
  Median     44 172
  Lowest     41 166
Innovation Center, EBITDA        
  Number of Estimates     15 17
  Highest     3 8
  Consensus 1 1 1 4
  Median     1 3
  Lowest     0 1
Innovation Center, EBIT        
  Number of Estimates     14 15
 Highest     -4 -17
  Consensus -5 -24 -5 -22
  Median     -5 -22
  Lowest     -7 -26
Corporate Activities, Sales        
  Number of Estimates     15 17
  Highest     20 75
  Consensus 18 71 18 69
  Median     18 71
  Lowest     15 64
Corporate Activities, EBITDA        
  Number of Estimates     15 17
  Highest     -24 -97
  Consensus -27 -105 -26 -102
  Median     -25 -100
  Lowest     -28 -114
Corporate Activities, EBIT        
  Number of Estimates     14 15
  Highest     -32 -133
  Consensus -35 -141 -35 -140
  Median     -35 -140
  Lowest     -38 -150
Profit for the period, before exceptional items - Cont. Ops.        
  Number of Estimates     15 18
  Highest     193.9 736.9
  Consensus 146.0 508.0 166.2 659.2
  Median     166.0 653.9
  Lowest     142.8 595.8
Net EPS before exceptional items - Cont. Ops.        
  Number of Estimates     15 18
  Highest     1.11 4.21
  Consensus 0.81 2.89 0.94 3.74
  Median     0.93 3.70
  Lowest     0.82 3.41

DSM Disclaimer

Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.